The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
NBFCs and OMC stocks offer margin of safety amid sector rotation: Rohit Srivastava
Rohit Srivastava suggests the market is holding gains with sector rotation, eyeing 25,300 on the Nifty. Key levels to watch are 24,494 for Nifty and
May 21, 2025